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ORIGINAL ARTICLE
Evaluation of zebrafish as a model to study the
pathogenesis of the opportunistic pathogen
Cronobacter turicensis
Alexander Fehr1,*, Athmanya K Eshwar2,*, Stephan CF Neuhauss3, Maja Ruetten1, Angelika Lehner2
and Lloyd Vaughan1
Bacteria belonging to the genus Cronobacter spp. have been recognized as causative agents of life-threatening systemic infections,
primarily in premature, low-birth weight and/or immune-compromised neonates. Knowledge remains scarce regarding the underlying
molecular mechanisms of disease development. In this study, we evaluated the use of a zebrafish model to study the pathogenesis of
Cronobacter turicensis LMG 23827T, a clinical isolate responsible for two fatal sepsis cases in neonates. Here, the microinjection of
approximately 50 colony forming units (CFUs) into the yolk sac resulted in the rapid multiplication of bacteria and dissemination into
the blood stream at 24 h post infection (hpi), followed by the development of a severe bacteremia and larval death within 3 days. In
contrast, the innate immune response of the embryos was sufficiently developed to control infection after the intravenous injection of
up to 104 CFUs of bacteria. Infection studies using an isogenic mutant devoid of surviving and replicating in human macrophages
(DfkpA) showed that this strain was highly attenuated in its ability to kill the larvae. In addition, the suitability of the zebrafish model
system to study the effectiveness of antibiotics to treat Cronobacter infections in zebrafish embryos was examined. Our data indicate
that the zebrafish model represents an excellent vertebrate model to study virulence-related aspects of this opportunistic pathogen
in vivo.
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INTRODUCTION
Cronobacter spp. are regarded as opportunistic facultative intracellular
pathogens associated with the ingestion of contaminated reconsti-
tuted infant formula and cause serious illness predominantly in low-
birth-weight preterm and neonatal infants.1,2 The clinical presentation
of Cronobacter infections include necrotizing enterocolitis (NEC),
bacteremia and meningitis, with case fatality rates ranging between
40% and 80%.3,4
The genus Cronobacter spp. - as proposed in 2008 - currently con-
sists of seven species according to the ‘‘List of prokaryotic names with
standing in nomenclature’’ and encompasses organisms that have
previously been identified as Enterobacter sakazakii.5,6,7 Recently, the
extension of the genus Cronobacter by three more Enterobacter species
was proposed by Brady et al.8; however, re-examination of the bio-
logical basis for this suggestion as performed in the study by Stephan
et al.9 does not support further revision of the taxon at this time.
Epidemiological studies and in vitro mammalian tissue culture
assays have shown that Cronobacter isolates demonstrate a variable
virulence phenotype. To date, only isolates of C. sakazakii, C. malo-
naticus and C. turicensis have been linked to infantile infections.10
Despite the progressive increase in research on Cronobacter patho-
genesis in the last decade, knowledge of the exact mechanisms of
infection remains fragmentary.11
As an orally transmitted pathogen, Cronobacter is thought to gain
entrance into the human body through the gastrointestinal tract,
where it may cause NEC or, by unknown mechanism(s), may enter
the systemic circulation without themanifestation of NEC.12 Once the
bacteria have entered the blood stream, they exhibit a tropism towards
the central nervous system, showing an increased propensity to cause
meningitis among low-birth-weight neonates and infants, while caus-
ing bacteremia or sepsis among slightly higher birth-weight infants.13
After crossing the blood brain barrier, the pathogen enters the brain,
where it causes ventriculitis, which can lead to the development of
hydrocephalus, or forms other sequelae, such as cysts or brain
abscesses.3,14
Most of the data available today have been acquired from in vitro
studies. In vivo studies to confirm and extend these observations from
cell culture have largely been concentrated on the neonatal rat, mouse
or gerbil as model organism.15-18 Although valuable information has
been obtained from these studies, the lack of possibilities for a real-
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time analysis and the need for laborious and invasive sample analysis
limit the use of mammalian experimental animals.
The nematode Caenorhabditis elegans has been alternatively used to
study Cronobacter virulence factors, exploiting the amenities of the
nematode system, such as easy cultivation and transparency.19
However, invertebrates are genetically not closely related to humans,
and their immune system shows many differences from the human
immune system. Hence, other models are needed to address specific
questions related to the innate immune response to a specific patho-
gen in detail.
The zebrafish (Danio rerio) may be considered a hybrid between
the mouse and invertebrate infection models. The most impressive
feature of this model is the possibility of performing non-invasive,
high-resolution, long-term time-lapse and time-course experiments
to visualize infection dynamics with fluorescent markers in the
transparent embryo. The small size, ease of breeding, high fertility
and genetic tractability of the zebrafish are further favorable features
that make the zebrafish embryo an attractive model organism.
Furthermore, the zebrafish immune system displays many similar-
ities to that of mammals, with counterparts for most of the human
immune cell types.20 The zebrafish innate immune system starts to
develop as early as 24 h post fertilization (hpf) with primitive
macrophages followed by neutrophils at 32-48 hpf. The develop-
ment of the adaptive immune system lags,21 which provides an
opportunity to study independently the innate immunity of the
larvae during the first days post fertilization (dpf). This situation
sets zebrafish apart from both in vitro and mammalian in vivo
infection models. Zebrafish larvae have previously been used to
study infections of other bacterial pathogens,22 including Listeria
monocytogenes, Salmonella Typhimurium and Shigella flexneri.23-25
In this study, we exploited the advantages of the zebrafish to invest-
igate infections by Cronobacter turicensis LMG 23827T in vivo. We
show here that Cronobacter causes lethal infection in zebrafish larvae,
with similarities to human cases. After having successfully established
the experimental parameters, the model was evaluated using a strain
devoid of a gene that has recently been described as a virulence factor
in C. turicensis. In addition, the model was used to study the effective-
ness of different antibiotics to treat Cronobacter infection.
MATERIALS AND METHODS
Bacterial strains and growth conditions
The bacterial strains used in this study are listed in Table 1.C. turicensis
LMG 23827T, a clinical isolate responsible for the death of two neo-
nates in Zurich in 2006 has been object of previous research.26,29-31,
Construction of the C. turicensis LMG 23827T DfkpA mutant, the
complemented mutant C. turicensis LMG 23827T DfkpA::fkpATetR,
as well as the mutant carrying the complementation vector
pCCR9TetR only (C. turicensis LMG 23827T DfkpA::pCCR9TetR) has
been described in detail in the study by Eshwar et al.28
The green fluorescent protein (GFP)-expressing strain C. turicensis
LMG 23827T::GFPKanR was constructed by Schmid et al.27 For selection
purposes, during zebrafish embryo infection experiments, C. turicensis
LMG 23827T::dsREDTetR, C. turicensis LMG 23827T DfkpA::dsREDTetR
as well as E. coli DH5a::dsREDTetR were constructed in this study by
transformation of vector pRZT3::dsREDTetR using standard methods.
Plasmid pRZT3::dsREDTetR carrying the red fluorescent protein was
a kind gift by A. M. van der Sar (VU University Medical Center, Dep-
artment of Medical Microbiology and Infection Control, Netherlands).
For cultivation, the strains were grown in 10 mL of Luria–Bertani
(LB, Difco, Beckton, Dickinson andCompany, Allschwil, Switzerland)
broth overnight at 37 6Cwith gentle shaking.C. turicensis LMG 23827T
variants/mutants were cultivated in LB broth supplemented
where appropriate with either tetracycline at 50 mg/L or kanamycin
at 50 mg/L.
For microinjection experiments, the bacteria were harvested by
centrifugation at 5000g for 10 min and washed once in 10 mL of
Dubelcco`s phosphate buffered saline (DPBS, Life Technologies, Zug,
Switzerland. After a second centrifugation step, the cells were resus-
pended in DPBS, and appropriate dilutions were prepared in DPBS.
Zebrafish lines and husbandry
Zebrafish (Danio rerio) strains used in this study were predominantly
albino lines as well as transgenic fish of the Tg(lyz:DsRED2)nz50 line
that produce red fluorescent protein in neutrophils, received as a kind
gift from Professor Philip Crosier, University of Auckland (New
Zealand).32 Adult fish were kept at a 14/10-h light/dark cycle at a
pH of 7.5 and 27 6C. Eggs were obtained from natural spawning
between adult fish which were set up pairwise in separate breeding
tanks. Embryos were raised in petri dishes containing E3 medium
(5mMNaCl, 0.17mMKCl, 0.33mMCaCl2, 0.33mMMgSO4) supple-
mented with 0.3 mg/L ofmethylene blue at 28 6C. From 24 hpf, 0.003%
1-phenyl-2-thiourea (PTU, Sigma-Aldrich, Buchs, Switzerland) was
added to prevent melanin synthesis. As albino lines lack melanized
chromophores, no PTU treatment was performed on these lines.
Embryo staging was performed according to Kimmel et al.33
Research was conducted with approval (NO 216/2012) from the
Veterinary Office, Public Health Department, Canton of Zurich
(Switzerland).
Microinjection experiments
Injections were conducted using borosilicate glass microcapillary
injection needles (1 mm outside diameter30.78 mm inside diameter,
Table 1 Bacterial strains and mutants used in this study
Strain/mutant Description Source and/or reference
Cronobacter turicensis LMG 23827T Wild type Neonate, Essers et al.26
Cronobacter turicensis LMG 23827T::GFP GFP-expressing, KanR Schmid et al.27
Cronobacter turicensis LMG 23827T::dsRED Harboring pRZT3::dsRED, TetR This study
Cronobacter turicensis LMG 23827T DfkpA In-frame mutant in mip-like gene Mutant collection Institute for Food Safety and Hygiene,
Eshwar et al.28
Cronobacter turicensis LMG 23827T DfkpA ::dsRED In-frame mutant in mip-like gene, harboring
pRZT3::dsRED, TetR
This study
Cronobacter turicensis LMG 23827T DfkpA::fkpA Mutant complemented with wt fkpA gene, TetR Eshwar et al.28
Cronobacter turicensis LMG 23827T DfkpA::pCCR9 Mutant harboring empty pCCR9 vector, TetR Eshwar et al.28
Escherichia coli DH5a::dsRED Harboring pRZT3::dsRED, TetR This study
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Science Products GmbH, Hofheim, Germany) and a PV830 Pneu-
matic PicoPump (World Precision Instruments, Sarasota, Florida,
USA). Prior to injection, embryos of 2 dpf were manually dechorio-
nated and anesthetized with 200 mg/L buffered tricaine (Sigma-
Aldrich, Buchs, Switzerland). Afterwards, the embryos were aligned
on an agar plate and injected with 50 to 104 colony forming units
(CFUs) in a 1-2-nL volume of a bacterial suspension in DPBS either
directly into the blood circulation, the hindbrain ventricle or into the
yolk sac. The volume of the injected suspension was previously
adjusted by injection of a droplet into mineral oil and measurement
of its approximate diameter over a scale bar. To determine the actual
number of CFU injected, we initially injected inoculum directly onto
the agar plates; however, a more precise determination of the injected
CFU can be obtained by plating five embryos separately immediately
after microinjection (0 hpi).
After injection, the infected embryos were allowed to recover in a
petri dish with fresh E3 medium for 15 min. To follow the infection
kinetics, the embryos were transferred to 6-well plates in groups of
approximately 15 embryos in 4 mL of E3 medium per well, incubated
at 28 6C and observed for signs of disease and survival under a stereo-
microscope twice a day.
Five embryos or larvae were collected at each time point, generally 0,
15, 24, and 48 hpi, and independently treated for bacterial enumera-
tion. The sampled larvae were euthanized with an overdose of 4 g/L
buffered tricaine and transferred to different buffers and fixatives for
subsequent analyses.
Bacterial enumeration by plate counting
The larvae were transferred to 1.5-mLmicrofuge tubes and disintegrated
by repeated pipetting and vortexing for 3 min in 1 mL of PBS supple-
mented with 1 % Triton X- 100 (Sigma-Aldrich, Buchs, Switzerland).
Subsequently, 100 mL of this mixture was plated onto LB selective
plates (i.e., tetracycline 50 mg/L for strains harboring pCCR9 or
pRZT3::dsRED or kanamycin 50 mg/L for selection for C. turicensis
LMG 23827T::GFP). The plates were incubated up to 48 h at 37 6C.
For survival assays, the embryos were similarly microinjected and
maintained individually in 24-well plates in E3 medium at 28 6C. At
regular time points after infection, the number of dead larvae was
determined visually based on the absence of a heartbeat.
Drug testing
Uninfected embryos were tested for antibiotic toxicity prior to the
start of this experiment by incubating embryos in E3 medium supple-
mented with one of three drugs. For drug screening, the infected
embryos were transferred into 24-well plates after yolk injections with
one embryo in each well in 1 mL of E3 medium containing either
8 mg/L ampicillin, 8 mg/L tetracycline, 4 mg/L nalidixic acid or were
left untreated (no drug added). As an additional control, a set of
uninfected embryos was incubated in E3 medium to determine
embryo quality. A negative control group was injected with DPBS.
Drugs were added to the water at the required concentrations.
Samples were collected and analyzed as described above.
Statistical analysis
Statistics and graph design were performed using GraphPad Prism 6
(GraphPad Software, San Diego, United States). Experiments were
performed at least three times, unless stated otherwise. The CFU of
groups of individual larva at various time points and under various
conditions were tested for significant differences by one-way ANOVA
with Bonferroni’s post-test.
Light microscopy, fluorescence imaging and image analysis
For histological examination, whole zebrafish larvae were fixed in 4%
paraformaldehyde at 4 6C and embedded in cubes of cooked egg white
to position them correctly for histological sections. These cubes con-
taining the larvae were dehydrated in an alcohol series of ascending
concentrations ending in xylene and afterwards embedded in paraffin.
Paraffin blocks were cut in 2-3-mm thin sections, mounted on glass
slides and stained using a routine protocol with hematoxylin and
eosin. Histological imaging was performed with a Leica DM LS S-
203675 (Leica microsystems, Heerbrugg, Switzerland) upright light
microscope.
Overview images of whole larvae were obtained with an Olympus
BX61 upright light microscope with both bright field and fluorescence
modules. The fluorescence filter cube used was optimized for DAPI/
FITC/TRIC. For higher resolution images, 3D-image stacks of whole
mount samples were prepared using a confocal laser-scanning micro-
scope (CLSM, Leica TCS SP5, Leica Microsystems, Heerbrugg,
Switzerland). GFP, dsRED and DAPI were sequentially excited with
the 405 nm, 488 nm and 561 nm laser lines, respectively, with emission
signals collected within the respective range of wave lengths. 3D image
stacks were collected sequentially (to prevent blue-green–red channel
cross-talk) according to Nyquist criteria and deconvolved using
HuygensPro via the Huygens Remote Manager v2.1.2 (SVI,
Netherlands). Images were further analyzed with Imaris 7.6.1
(Bitplane, Zurich, Switzerland) and aligned with Adobe Photoshop
Elements 12.
Transmission electron microscopy
For transmission electron microscopy (TEM), the larvae were fixed in
a mixed solution of 1 % paraformaldehyde (Sigma-Aldrich, Buchs,
Switzerland) and 2.5 % glutaraldehyde (Sigma-Aldrich, Buchs,
Switzerland) in 0.1 M sodium phosphate buffer, pH 7.5 at 4 6C over-
night. Afterwards, the samples were prepared for embedding into
epoxy resin and for transmission electron microscopy according to
standard procedures. Pospischil et al., 1990). Epoxy resin blocks were
screened for larvae using semithin sections (1 mm), which were stained
with toluidine blue (Sigma-Aldrich, Buchs, Switzerland) to visualize
tissue. Ultrathin sections (80 nm) were mounted on copper grids
(Merck Eurolab AG, Dietlikon, Switzerland), contrasted with uranyl
acetate dihydrate (Sigma-Aldrich, Buchs, Switzerland) and lead citrate
(Merck Eurolab AG, Dietlikon, Switzerland) and investigated using a
Philips CM10 transmission electron microscope (Philips Electron
Optics, Eindhoven, The Netherlands). Images were processed with
Imaris (Bitplane AG, Zurich, Switzerland) and assembled for publica-
tion using Adobe Photoshop.
Confocal live imaging
To perform high-resolution confocal live imaging, the injected larvae
were positioned in 35-mm glass-bottom dishes (Iwaki, Eurodyne
Limited, Lindale, UK). The entire larva was covered and immobilized
with 1 % low-melting-point agarose solution. A total of 2 mL of fish
water containing tricaine was added to cover the immobilized larvae.
Confocal microscopy was performed at 26 6C. A Leica SP8 (Leica
Microsystems, Heerbrugg, Switzerland) automated upright confocal
laser scanning microscope allowing simultaneous acquisition of three
fluorescent channels and one bright field or differential interference
contrast (DIC) was used. The detection system in this microscope is
equipped with two photomultiplier tubes and a hybrid detector and a
203water immersion objective (HC PL APO NA-0.5 WD-3.5 mm)
was used to image live infected larvae. The 4D images produced by the
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time-lapse acquisitions were processed, clipped, examined and inter-
preted using the Imaris software. Maximum intensity projection was
used to project developed Z-stacks and files were exported in AVI
format. To mount figures, frames captured from AVI files were
handled using Photoshop software. Imaris software was used to crop
and annotate the exported AVI files, then compressed and converted
into QuickTime movies with QuickTime Pro software.
RESULTS
Infection of zebrafish larvae with Cronobacter via microinjection
is lethal
To develop a Cronobacter turicensis infection model in a genetically
tractable vertebrate model host, we investigated whether the strain
C. turicensis LMG 23827T, a strain originally isolated from a fatal
neonatal infection could lethally infect zebrafish embryos at 2 dpf.
Initial experiments to infect zebrafish with this strain by immersing
dechorionated embryos in a suspension of strain LMG 23827T failed.
Lethality required high concentrations of strain LMG 23827T or LMG
23827T::GFP (109–1010 CFUs/mL), and the experiments were not
reproducible (data not shown). Similar results were reported for
co-infection experiments using other pathogens under static immer-
sion conditions.34 Moreover, using the bath immersion experimental
design, we were unable to establish a stable infection in the digestive
systemof the larvae. Similar observations were reported in the study by
Levraud et al.23 showing that zebrafish embryos were not susceptible
to oral infection with Listeria monocytogenes.
Therefore, we next focused on the possibility of introducing LMG
23827T or LMG 23827T::GFP into 2 dpf-old embryos directly by
microinjection into the yolk sac, the common cardinal vein or the
hindbrain ventricle, thereby exploiting the advantage of easy fluor-
escent tracking by using the GFP transgenic strain C. turicensis LMG
23827T::GFP with concentrations ranging from 50 to 104 CFUs. Yolk
injections were performed into the posterior part of the yolk sac before
the extension to prevent perforation of the common cardinal vein,
which widely covers the anterior part of the yolk. After injection, the
embryos were transferred into 24-well plates containing fresh E3med-
ium and further incubated at 28 6C. Signs of disease, larval survival,
fluorescence pattern of bacteria, and bacterial load were examined
over time. The bacterial load was determined by counting the CFU
of homogenates of whole individual larva plated on agar plates con-
taining kanamycin for selection purposes at 37 6C overnight.
Intravenous injections of up to 104 CFUs and hindbrain injections
of up to 103 CFUs did not result in an apparent infection. Bacteria were
cleared from the system within the first 24 hpi, and the larvae showed
no indication of disease or mortality (data not shown). However,
injections of as little as 50 CFUs into the yolk resulted in the rapid
replication ofCronobacter inside the yolk sac of approximately two log
units within 24 hpi and a subsequent spreading into the larval blood
stream between 24 and 48 hpi (Figure 1A). Confocal imaging revealed
bacteria accumulating at the surface of the yolk sac before further
spreading into the larvae (Figure 1B). The bacteria inside the yolk
could be found dividing by binary fission (Figures 1C and 1D). The
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Figure 1 Injection of C. turicensis into the yolk of 2-dpf embryos causes lethal infection. (A) Appearance of larvae at 24 and 48 hpi under a fluorescence light
microscope after injection of 50 CFU of C. turicensis LMG 23827T::GFP into the yolk sac. At 24 hpi, replication of GFP-expressing bacteria and further spreading into
the yolk are visible. At 48 hpi, continuous replication and spreading inside the whole yolk sac and also into further tissues of the larvae can be observed. (B) CLSM-
acquired 3D stack showing part of the border between the yolk sac and the larva in a region close to the head. GFP-expressing bacteria accumulate on the surface of the
yolk. Some have already crossed the barrier, distributing in the larva. (C andD) Inside the yolk, many dividing bacteria can be observed, confirmed by DAPI staining of
bacterial and host DNA. The images showmerged channels for DIC/GFP (B), DAPI/GFP (C) or DAPI alone (D). (E) Mean growth curve of C. turicensis inside infected
larvae with a starting inoculum of approximately 50 CFU. Enumeration was performed by plating homogenates of whole individual larvae at different time points on
selective agar plates at 37 6C and subsequent counting of bacterial colonies. (F) Survival rates of larvae injected with 50CFUC. turicensis LMG23827T::GFP or 50 CFU
E. coli DH5a::dsRED or 1 nL of DPBS or left uninjected, following incubation at 28 6C for 72 hpi.
A zebrafish model for Cronobacter infection
A Fehr et al.
4
Emerging Microbes and Infections
bacterial load continued to increase for another log unit at the same
time (Figure 1E). Mortality after yolk injections increased up to 100%
at 72 hpi, while microinjection of equal or greater numbers of E. coli
DH5a::dsRED resulted in complete survival of the infected larvae
(Figure 1F).
The traverse of Cronobacter to the bloodstream could be observed
throughout the entire length of the boundary between yolk and vas-
culature (Figures 2A-2D), followed by an accumulation of bacterial
clusters in the capillaries of the trunk and the eyes (Figures 2E and 2F).
Infection progression and pathology
Larvae that were injected into the yolk sac showed at 30-48 hpi small
132 mm, rod-shaped bacteria free and intracytoplasmic in leukocytes
as macrophages or neutrophils in the yolk sac (Figures 3A and 3B) and
in the lumina of several blood vessels, especially close to the eyes
and brain (Figures 3C and 3D). The number of macrophages and
neutrophils within the yolk sac lining the wall was increased compared
with control animals (data not shown).
TEM images showed long rods of 2-mm length and 1-mmwidth that
were lying free in the protein of the yolk sac (Figure 3E). The bacteria
contained a thin cell wall, typical for gram-negative rods, and a loose
chromatin pattern. Some bacteria were dividing, which could also be
observed by confocal microscopy. Some leukocytes containing bac-
teria showed degeneration as large pale intracytoplasmic vacuolation,
crystolysis and swelling of mitochondria, increase of lipid globules or
dilation or even fragmentation of Golgi or endoplasmic reticulum
(Figure 3F). Additional signs of degeneration, such as karyorhexis,
karyopyknosis and hypereosinophilia of the cytoplasm, were observed
inmany leukocytes (Figure 3F). The presence of neutrophils inside the
yolk sack was confirmed by confocal imaging, where labeled neutro-
phils were associated with the bacteria (Figure 4).
Innate immune response to Cronobacter infection (CLSM Leica SP8
– live imaging)
To visualize the dynamics of Cronobacter replication and the innate
immune reaction to the infection inside the yolk, we utilized trans-
genic 2 dpf zebrafish embryos of the Tg(lyz:DsRED2)nz50 line, which
harbor red fluorescent protein-expressing neutrophils. These embryos
were injectedwith a dose of approximately 50 CFUs ofGFP-expressing
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Figure 2 Confocal imaging of DAPI-stained larva after yolk injection of GFP-
expressing Cronobacter reveals bacteria inside the yolk and the bloodstream of
the larva. At 24 hpi, the bacteria have spread from the initial injection site into the
extension part of the yolk sac (A and B). The rod-shaped bacteria are forming
clusters and replicate by binary fission near the barrier between yolk and the
vasculature of the larva (C and D). At 48 hpi, numerous bacteria are visible in the
blood circulation of the trunk (E) and the eye (F), forming clusters and accu-
mulating in the capillaries. DIC/GFP (A and C) and DAPI/GFP (B, D, E and F)
channels are merged, respectively.
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Figure 3 Pathology of the infection. Histological hematoxylin and eosin-stained
sections of infected larvae at 48 hpi. (A) The overview shows a longitudinal section
through the yolk and the head region of a whole larva embedded in egg white. (B)
Under highermagnification, clusters and single bacteria are visible inside the yolk
(black arrows). (C and D) Further bacteria can be observed in the blood circula-
tion, accumulating in capillaries of the eyes and brain (black arrows). (E) TEM
imaging of the barrier region between yolk and larva shows bacteria distributed
inside but also lining the border of the yolk (white arrow). (F) TEM imaging of
bacteria (arrow) phagocytosed by an innate immune cell embedded in the yolk
(star). The cell is degrading, as indicated by the swelling and fragmentation of
their organelles (asterisk).
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C. turicensis LMG 23827T::GFP into the yolk sac at 2 dpf. The
Cronobacter-host interactionswere captured in real-time at 24 hpi using
high-resolution confocal laser scanningmicroscopy for a time course of
approximately 2 h. We observed rapid replication ofCronobacter inside
the yolk forming several clusters of motile bacteria. Over time, an
increasing number of red fluorescent neutrophils was recruited to the
yolk taking up the bacteria but were unable to control the proliferation
and spreading of Cronobacter (Figure 4, Supplementary Video).
Drug screening
For the next step, we determined whether the zebrafish model may be
suitable for testing the effectiveness of antimicrobial agents to clear
infections with C. turicensis LMG 23827T. Prior to these experiments,
the minimum inhibitory concentrations (MICs) of a selection of
antimicrobial drugs belonging to different antibiotic classes were
determined for the wild type C. turicensis LMG 23827T as well as the
GFP-expressing strain C. turicensis LMG 23827T::GFPKanR using
E-test strips (bioMerieux, Marcy-l-Etoile, France) on Mu¨ller Hinton
agar, according to the recommendations of the manufacturer. The
following MIC values (in mg/L) were determined for both strains:
ampicillin, 0.75; tetracycline, 1.5; cephalothin, 6; rifampicin, 2; genta-
micin, 0.38; polymyxin B, 0.094; nalidixic acid, 0.5; and chlorampheni-
col, 64. Conversion of theMICdata into qualitative categories using the
European Committee on Antimicrobial Susceptibility Testing break-
points suggested that C. turicensis LMG 23827T was susceptible to all
tested antibiotics with exception of rifampicin and chloramphenicol.
There was no variation among the wild type and its GFP variant (data
not shown).
Based on these findings, we tested the activity of ampicillin, tetra-
cycline and nalidixic acid against Cronobacter in vivo in the zebrafish
infection model. The embryos were tested for antibiotic toxicity prior
to the start of this experiment. Embryos in E3 medium supplemented
with tetracycline or ampicillin did not exhibit any toxic effect and/or
mortality; however, the embryos exposed to nalidixic acid exhibited
pericardial edema but nomortality (data not shown). Because all three
antibiotics are water soluble, they were administered to the fish water
after the yolk injections of Cronobacter or DPBS as control. Another
control group was infected but left without treatment. The distri-
bution ofCronobacterwithin the infected larvae was followed by fluor-
escence microscopy after the injection of the GFP-expressing strain
(Figure 5A). The survival rate (Figure 5B) and the bacterial load
(Figure 5C) were determined for individual larvae by microscopic
observation and plate count enumeration. While treatment with tet-
racycline had no significant effect on the bacterial load and survival,
treatment with ampicillin significantly reduced the bacterial load
compared with untreated larvae, but did not increase survival.
However, treatment with nalidixic acid had a significant impact on
both bacterial load and the survival of infected larvae. At 24 hpi,
Cronobacter could no longer be detected in these larvae by plate count
or by fluorescence microscopy. Furthermore, the survival rate was
close to 100% at 72 hpi. Interestingly, during treatment with nalidixic
acid, the formation of pericardial edema was observed in nearly 100%
of all larvae.
FkpA is an important virulence factor for Cronobacter turicensis
infection in zebrafish embryos
Given the previous results and observations concerning the behavior
of Cronobacter and innate immune cells after injection into the yolk
sac, we concluded that internalization and survival ofCronobacter cells
in professional phagocytes of the innate immune system, such as
macrophages present in the yolk and/or the blood stream, play a key
role during the infection process. In a recent study, the eminent role of
a functional FkpA (also known as macrophage infectivity potentiator-
like protein) in survival and replication in human macrophages was
reported for C. turicensis LMG 23827T.28 We therefore tested a DfkpA
in-frame mutant for attenuated pathogenicity in infection experi-
ments using the above-described experimental design; C. turicensis
LMG 23827T::dsRED served as control. The survival rate at 48 hpi
increased to approximately 70 % for DfkpA::dsRED mutant-injected
larvae (Figure 6A), thus confirming the role of this gene as a patho-
genicity factor during Cronobacter infection in zebrafish embryos.
Furthermore, the bacterial load inDfkpA::dsREDmutant (C. turicensis
LMG 23827T DfkpA::dsRED)-injected larvae was significantly lower
compared with the control group (Figures 6B and 6C). Injection
experiments using the complemented mutant strain (C. turicensis
LMG 23827T DfkpA::fkpA) resulted in a lower survival rate and a
higher bacterial load, whereas control experiments using the mutant
strain transformed with the vector alone (C. turicensis LMG 23827T
DfkpA::pCCR9) yielded survival rates and bacterial loads comparable
to the ones observed in the DfkpA::dsRED mutant-injection experi-
ments (Figures 6A-6C).
DISCUSSION
To adopt the zebrafish model to study these human opportunistic
pathogens, several experimental designs were used. As infecting the
embryos via the oral route proved unsuccessful, we focused on intro-
ducing the pathogens into the animal circulation system via micro-
injection. However, injection of up to 10 000 CFUs into the cardinal
vein of 2 dpf old zebrafish larvae did not result in clinical signs of
infection in the embryos. Fluorescence microscopy showed that no
replication occurred and the bacteria were cleared instead within 24
hpi (data not shown). In fact, it has been reported that Cronobacter
spp. exhibit only a ‘‘moderate’’ capability to survive in human blood
or serum. Thus, it was shown for C. sakazakii, which is closely related
to C. turicensis, that a minimum of a two-log reduction of a bacterial
inoculum occurred within a 30-min exposure in 50% human blood.35
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Figure 4 C. turicensis rapidly replicates inside the yolk and initiates an innate
immune response with recruitment of neutrophils (magnification 103). Live
imaging of the replication of C. turicensis LMG 23827T::GFP after injection of
50 CFU into the yolk of 2-dpf transgenic Tg(lyz:DsRED2)nz50 zebrafish
embryos, possessing red fluorescent neutrophils. Rapid replication and cluster-
ing of the bacteria can be observed, which readily induced recruitment of neu-
trophils into the yolk sac. Live imaging was performed using a CLSM Leica SP8
over a time course of approximately 2 h.
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In a recent study, similar observations were reported for zebrafish
larvae infection studies on Staphylococcus epidermidis when compar-
ing the results from yolk injection versus blood stream (caudal vein)
injection experiments.36 Within this study, it was speculated that the
better survival rate of the bacteria injected in the yolk may be
explained by several factors (or a combination of those), such as
repeated cycles of invasion from the yolk and/or that internalization
and proliferation of bacteria in the yolk results in ‘‘priming’’ to an
infectious growth strategy but also alternations of the host immune
system due to the prolonged exposure to high numbers of bacteria
were suggested.
Thus, we concluded that the yolk injection is a uniquely suitable
infection site. We showed that, following injection of as few as 50
CFUs, the bacteria were rapidly replicating both freely in the yolk as
well as internalized in the primitive macrophages and neutrophils
present in the yolk sac. The affected leucocytes were not killed
rapidly, and the phagocytosed bacteria did not escape from these
cells. At 24 hpi, free bacteria as well as infected macrophages were
lining up near the border of the yolk sac, where a traverse into the
blood vessel and the surrounding tissue was observed. At later time
points (30 hpi – 48 hpi), bacteria colonized the lumina of small blood
vessels, especially those close to the eyes and brain. Accumulation of
bacteria in the capillaries of the eyes is a typical feature for septicemia
and bacteremia in fish. At these sites, the bacteria were observed to
form micro-colonies in which they replicated and from which they
were shed into the circulation. Thus, during infection in zebrafish
embryos, a combination of extracellular and intracellular replication
of Cronobacter could be observed.
In the next experiment, a selection of antimicrobial compounds was
tested for their ability to cure aCronobacter infection in the embryos by
application of the drugs to the fish water. Given that the antibiotic
concentrations applied were previously shown to be lethal for the
bacteria in vitro, we can only speculate why the ampicillin and tetra-
cycline treatments were not effective in vivo. One explanation may be
that the molecules are not reaching lethal concentrations at the pre-
dominant infection site inside the yolk, which could be influenced by
the size of the molecules, the local pH or the acid/base character of the
antimicrobial substance. Nalidixic acid was the only drug to prove
efficient in killing the bacteria inside the host. Although the survival
rate of infected fishes was close to 100% after 72 hpi, pericardial edema
was observed during drug treatment. Interestingly, similar adverse
effects, namely, increased intracranial pressure leading to the forma-
tion of cerebral edema, have been reported in humans, especially in
infants and young children after treatment with nalidixic acid.37 This
result also underlines that zebrafish larvae can show typical reactions
to other influencing factors, such as antibiotic treatment, and can thus
be used as a drug screeningmodel not only to test the efficacy of a drug
against the pathogen in vivo but also to predict possible adverse effects
on the patient.
It has been shown thatCronobacter spp. are capable of surviving and
replicating within humanmacrophages for up to 96 h, and, in a recent
study, the FkpA protein was identified as a key factor involved in this
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Figure 5 Effects of antibiotic drugs on an infection of C. turicensis in zebrafish larvae. (A) Fluorescence light microscopic appearance of representative larvae at
different time points after the injection of C. turicensis LMG 23827T::GFP into the yolk sac at 2 dpf and subsequent treatment with 8 mg/mL ampicillin, 8 mg/mL
tetracycline or 4mg/mL nalidixic acid or without treatment (magnification 403). Larvae treatedwith nalidixic acid exhibited the formation of pericardial edema at 48 hpi
(white arrow) (B) Survival rates of infected larvae with and without treatment with various antibiotics and of control larvae injected with DPBS or uninjected controls are
shown. (C) Quantification of the bacterial load of individual larvae at different time points and under different treatment conditions is depicted. Significant differences
could be observed at 48 hpi for the treatment with ampicillin and nalidixic acid compared with untreated larvae. Statistical analysis was performed by one-way ANOVA
with Bonferroni’s posttest. ***, P,0.001; ns, not significant. Mean values 6SEM are shown by horizontal bars.
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ability. When using an fkpA mutant that is defective in survival and
replication in human macrophages, pathogenicity was strongly atte-
nuated in the zebrafish model. This finding provides evidence that
macrophages and other phagocytic cells can play a crucial role in the
process of traversing physical barriers such as epithelia and endothelia
and, by this, promote further systemic spreading of intracellular bac-
terial pathogens within the host organism.
Taken together, by exploiting the favorable features of the zebrafish
within this study, we have established and applied the first zebrafish
model to study the pathogenesis of C. turicensis in vivo. Our model
provides interesting insights into the pathogenic nature of these oppor-
tunistic facultative intracellular pathogens and also shows the reaction
of the innate immune system to an infection in real time. With the
experimental design developed in this study, the results can be obtained
within days, and the number of experiments can be easily scaled up.
Thus, large numbers of bacterialmutants and strains can be screened for
virulence-related factors of Cronobacter, providing a promising tool to
discover further detailed features of Cronobacter virulence and the
counteracting innate immune response in future studies.
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